Jonathan CP Roos (PMFA)

Harvard, Cambridge & Moorfields-trained Consultant Oculoplastic Surgeon and academic based in London at www.FaceRestoration.com. Publishes in the world’s leading medical journals and lectures internationally on aesthetics, eyelid diseases and thyroid eyes.

JOURNAL REVIEWED: New England Journal of Medicine | Ophthalmic Epidemiology

Latest Contribution

Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema

1 April 2015 | | Retina / Uvea / Vitreous

Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...